In-feed supplementation of antibiotics was firstly reported to promote growth in chickens (Moore et al., 1946) and subsequently in pigs (Jukes et al., 1950; Luecke et al., 1950). Since then, antibiotics have been routinely used in livestock production at subtherapeutic levels for disease prevention and growth promotion and are more commonly known as antibiotic growth promoters (Dibner and Richards, 2005). Unfortunately, continuous long-term exposure of gut commensals and pathogens to low-dose antibiotics in livestock animals has been linked to increased emergence of antibiotic-resistant pathogens (Dibner and Richards, 2005; Lhermie et al., 2016; Thanner et al., 2016). Consequently, the European Union has banned the use of all antibiotics for the purpose of growth promotion since January 2006 (Seal et al., 2013), and the United States has taken a similar measure to phase out the application of medically important antibiotics for livestock production starting January 2017. A shift in governmental policy and public opinion has resulted in an urgent need for alternatives to in-feed antibiotics in order to ensure animal health and production efficiency with a minimum risk of triggering antimicrobial resistance.
Antibiotic alternatives such as organic acids, probiotics, prebiotics, and essential oils have been used for decades, but with limited success (Seal et al., 2013; Stanton, 2013). More effective antibiotic alternatives are, therefore, needed. Host defense peptides (HDP), also known as antimicrobial peptides, possess direct antimicrobial, immunomodulatory and often barrier protective activities (Hancock et al., 2012; Hilchie et al., 2013; Mansour et al., 2014; Robinson et al., 2015). A great majority of these HDP are expressed by mucosal epithelial cells of the digestive, respiratory, and urogenital tracts (Lyu et al., 2015). The strategies to increase HDP accumulation on mucosal surfaces will conceivably enhance animal immunity, health and disease resistance without relying on antibiotics. Consistently, accumulating evidence suggests the potential for HDP to be developed as novel antibiotic alternatives (Sang and Blecha, 2008; Robinson et al., 2015; Xiao et al., 2015; Wang et al., 2016). While dietary supplementation of exogenous HDP have shown promise in swine and chickens (Xiao et al., 2015; Wang et al., 2016), modulation of endogenous HDP to ensure animal growth and immunity is just beginning to be explored, with multiple compounds being identified with the ability to induce endogenous HDP synthesis (Campbell et al., 2012; van der Does et al., 2012; Lyu et al., 2015). The goal of this review is to summarize the relevant work regarding induction of HDP by dietary compounds, focusing specifically on butyrate and vitamin D.
2. Host defense peptides as effectors of innate immunity
2.1. Classification of HDP
Host defense peptides consist of a large group of diverse small peptides with direct microbicidal activities that exist in virtually all species of life and constitute an important mechanism of the first-line defense (Mansour et al., 2014). In vertebrates, a majority of HDP belong to either the defensin or cathelicidin family. Members of the defensin family contain 3 conserved disulfide bridges that form 2-3 antiparallel b-sheets (Selsted and Ouellette, 2005). Based upon the explicit spacing pattern of the cysteine residues, defensins are further categorized into a-, b-, and q-defensins. While q-defensins have only been found in primates, b-defensins are present in virtually all vertebrate animals, with only certain mammalian species harboring a-defensins (Selsted and Ouellette, 2005). Mammalian bdefensin genes are located in several separate clusters on different chromosomes, with the a- and q-defensin genes, if any, existing within one of the b-defensin clusters (Patil et al., 2004, 2005). The human genome harbors 6 functional a-defensins and 5 pseudogenes in one cluster, 39 b-defensins in 5 different clusters, and one q-defensin pseudogene (Schutte et al., 2002; Patil et al., 2004, 2005). On the other hand, at least 29 b-defensins are clustered on 4 different chromosomes in pigs (Choi et al., 2012), whereas the bovine genome encodes a minimum of 57 b-defensins in 4 separate clusters (Meade et al., 2014). In chickens, a total of 14 b-defensin genes are located in tandem in a single cluster (Xiao et al., 2004; Lynn et al., 2007).
Cathelicidins are identified by the presence of a highly conserved cathelin domain that is cleaved off to release a biologically active, mature peptide with diverse sequences (Zanetti, 2004). The human genome only contains one cathelicidin gene, known as human cationic antimicrobial peptide -18 (hCAP-18), cyclic Adenosine monophosphate (CAMP) or LL-37 (Gudmundsson et al., 1996). Four cathelicidin genes have been identified in chickens, namely fowlicidins 1-3 (or CATH1-3) (Xiao et al., 2006) and cathelicidin-B1 (Goitsuka et al., 2007) while 10 cathelicidin genes have been reported in cattle (Whelehan et al., 2014) and 11 cathelicidin genes in pigs (Sang and Blecha, 2009).
Defensins, and b-defensins in particular, are expressed in epithelial and phagocytic cells in a variety of different tissues, primarily on the mucosal surfaces lining the gastrointestinal, respiratory, and urogenital tracts along with the skin (Selsted and Ouellette, 2005). Cathelicidins are also present in various epithelial cells, but with more abundant expression in mammalian neutrophils (Selsted and Ouellette, 2005) or avian heterophils (Cuperus et al., 2013; Zhang and Sunkara, 2014). Additionally, chicken cathelicidin-B1 is expressed in the M cells of the bursa of Fabricius (Goitsuka et al., 2007).
2.2. Pleiotropic effects of HDP
Host defense peptides are characterized by their direct antimicrobial activities against a range of pathogens. Cathelicidins and b-defensins are active against Gram-negative and Gram-positive bacteria along with certain viruses, fungi, and protozoa (Zasloff, 2002; Takahashi et al., 2010; Wang, 2014). Host defense peptides are generally positively charged and amphipathic enabling them to bind to negatively charged phospholipids on bacterial membranes through physical electrostatic interactions. Once bound, hydrophobic regions of the HDP are inserted into the membrane bilayers to form pores mainly through ‘barrel-stave’, ‘carpet’ or ‘toroidal-pore’ mechanisms (Brogden, 2005; Takahashi et al., 2010). Certain HDP such as human a-defensin human neutrophil peptides-1 (HNP-1) and porcine cathelicidin prolinearginine rich-39 (PR-39) are also able to enter the bacterial cells and interfere with DNA and protein synthesis, protein folding, or cell wall synthesis (Brogden, 2005). These modes of action make it extremely difficult for bacteria to develop resistance to HDP even through millions of years of coevolution, although certain bacteria are able to resist HDP killing by reducing the negative charge on the membrane (Peschel and Sahl, 2006). This is exemplified by the ability of Salmonella enterica and Pseudomonas aeruginosa to reduce their membrane affinity for HDP by incorporating positively charged aminoarabinose into lipid A (Ernst et al., 2001; Miller et al., 2005).
Besides the antimicrobial activities, HDP possess profound immunomodulatory and barrier protective functions as well. Many HDP are chemotactic to neutrophils (or heterophils in chickens), monocytes, lymphocytes, or dendritic cells, with the ability to further activate macrophages and dendritic cells (Hilchie et al., 2013; Mansour et al., 2014). Chicken CATH-1 has the capacity to recruit neutrophils and activate macrophages in mice (Bommineni et al., 2014), while protecting mice from infection (Bommineni et al., 2010, 2014). Three bovine b-defensins were also found to be chemotactic to immature dendritic cells (Mackenzie-Dyck et al., 2011). Several, but not all human defensins, were recently shown to have mucosal barrier protective properties by directly upregulating mucin and tight junction protein expression (Robinson et al., 2015). Porcine cathelicidin PR-39 is also capable of improving angiogenesis and wound repair with the ability to suppress nicotinamide adenine dinucleotide phosphate (NADPH) oxidase assembly and activation (Gallo et al., 1994; Shi et al., 1996).
2.3. Impact of exogenous HDP on growth and disease prevention
Consistent with their antimicrobial, immunomodulatory, and barrier protective activities, dietary supplementation of synthetic or recombinant HDP has been found to enhance animal growth and gut health, particularly in the context of disease (Xiao et al., 2015), highlighting the potential of HDP to be developed as antibiotic alternatives for disease control and prevention. Weanling pigs challenged with enterotoxic Escherichia coli show an improvement in growth performance with a decrease in the incidence of diarrhea when supplemented with colicin E1 (a bacteriocin) (Cutler et al., 2007), recombinant cecropin A/D (a silkworm HDP) (Wu et al., 2012), recombinant lactoferrin (a bovine HDP) (Tang et al., 2012), or a mixture of three recombinant HDP (Xiong et al., 2014). In healthy piglets, presence of a synthetic HDP is also capable of improving growth performance along with intestinal morphology and digestibility (Yoon et al., 2013). Similar results have also been observed in broilers. Dietary inclusion of a synthetic HDP or recombinant cecropin A/D resulted in enhanced growth performance associated with improved intestinal morphology and nutrient digestibility (Wen and He, 2012; Choi et al., 2013a, 2013b)
Although direct feeding of synthetic or recombinant HDP show their potential to be used as antibiotic alternatives, this approach is not expected to be efficient as a majority of exogenous HDP would be digested in the stomach and upper intestinal tract without efficiently reaching the lower intestinal tract where most pathogens reside. Moreover, it remains unclear whether this strategy is cost-effective and commercially viable for livestock applications as the cost of producing synthetic or recombinant HDP is expected to be substantial. Instead, dietary modulation of the synthesis of endogenous HDP may be a better approach. Currently, a range of small-molecule compounds have been found to induce HDP synthesis in humans and livestock animals (Campbell et al., 2012; van der Does et al., 2012; Lyu et al., 2015; Yedery and Jerse, 2015). Of these compounds, butyrate and vitamin D are among the earliest identified and most potent, so they will be the focus of this review.
3.1. Physiological roles of butyrate
Short-chain fatty acids (SCFA) are a group of fatty acids consisting of less than 6 carbons that are produced by bacterial fermentation of non-digestible carbohydrates in the large intestine of animals as well as the rumen of ruminant animals (Hamer et al., 2008; Canani et al., 2011). Acetate, propionate, and butyrate are the primary SCFA produced, with acetate comprising the greatest percentage. Butyrate encompasses the smallest percentage of SCFA produced, but is the primary energy source for colonocytes in humans (Canani et al., 2011). The amount of butyrate produced through bacterial fermentation varies greatly with animal species, age, gastrointestinal location, and diet (Rehman et al., 2007). In chickens, for a typical corn and soybean meal diet, the butyrate concentration in small intestine (duodenum, jejunum, and ileum) is typically 0.1 to 0.2 mmol/L of the digesta, while it can reach 7 to 17 mmol/L in the cecum, depending upon the bird age (Rehman et al., 2007). In weanling pigs, butyrate concentrations in the jejunum, ileum, and cecum was reported to be 2.2, 2.8, and 10.4 mmol/L of the digesta, respectively (Franklin et al., 2002). In cattle, butyrate amounts to 10 to 15 mmol/L in the rumen fluid (Balch and Rowland, 1957). Shortchain fatty acids produced in the large intestine are estimated to contribute 5% to 15% of the total caloric requirements of humans (Bergman, 1990), while providing approximately 24% of the energy for heat production in pigs (Yen et al., 1991). Short-chain fatty acids production in the cecum of steers provides approximately 8% of metabolizable energy, while ruminal SCFA contribute 50% to 75% (Siciliano-Jones and Murphy, 1989).
Apart from being an important energy source for the intestinal cells, SCFA and butyrate, in particular, exert a range of mucosal protective effects by suppressing carcinogenesis, inflammation, and barrier permeability (Hamer et al., 2008; Canani et al., 2011). Butyrate is capable of preventing colorectal cancers through inhibition of tumor proliferation, stimulation of differentiation, and induction of apoptosis in cancerous cells (Scheppach et al., 1995; Canani et al., 2011). Paradoxically, butyrate stimulates cell proliferation and differentiation while inhibiting apoptosis in normal intestinal cells in humans, cattle, and pigs (Scheppach et al., 1995; Kotunia et al., 2004; Mazzoni et al., 2008; Guilloteau et al., 2010). Butyrate promotes intestinal barrier function by facilitating tight junction assembly and inducing the expression and synthesis of multiple tight junction proteins and mucin-2 (Ploger et al., 2012). Moreover, butyrate displays potent anti-inflammatory effects through suppression of pro-inflammatory cytokines such as interleukin (IL)-1b, IL-12, and tumor necrosis factor-a (TNF-a) (Saemann € et al., 2000; Nancey et al., 2002; Fukae et al., 2005), while inducing anti-inflammatory cytokine, IL-10, in humans (Saemann et al., € 2000). In chickens, butyrate has a minimum effect on the expression of IL-1b, IL-6, interferon-g (IFN- g) or nitric oxide, but suppresses the induction of these cytokines by lipopolysaccharides (LPS) both in vitro and in vivo (Sunkara et al., 2011; Zhang et al., 2011; Zhou et al., 2014). Similarly, dietary supplementation of weanling pigs with sodium butyrate reduces serum levels of IL-6 and TNF-a (Wen et al., 2012).
3.2. Role of butyrate in gut health and animal performance
Consistent with a plethora of beneficial effects of butyrate, an improvement in animal health and performance is often observed following butyrate supplementation. Intestinal morphology of broilers fed 0.5, 1 or 2 g/kg of unprotected sodium butyrate shows an increased villus height to crypt depth ratio (Hu and Guo, 2007), while oral gavage of sodium butyrate at 3 g/kg of the daily intake of milk dry matter during the suckling phase improves apparent digestibility of dry matter, organic matter, and nitrogen of growing pigs (Le Gall et al., 2009). Inclusion of 2 g/kg sodium butyrate in calf milk replacer or starter diets stimulates rumen development resulting in increased dry matter intake, metabolizable energy, and crude protein intake along with a decrease in the incidence of scours (Gorka et al., 2011 ). Multiple studies have reported improved growth performance, particularly in the context of infections, in broilers when supplemented with 4 g/kg butyrate glycerides or 1 g/kg sodium butyrate (Leeson et al., 2005; Zhang et al., 2011). Similarly, the growth performance of growing and weanling pigs were also improved when fed 1.7 or 2 g/kg sodium butyrate (Galfi and Bokori, 1990; Xiong et al., 2016). This is also the case in dairy calves when supplemented with 3 g/kg of dry matter or 2 g/kg of the diet (Guilloteau et al., 2009; Gorka et al., 2011 ). However, butyrate supplementation appears to provide no obvious benefits in growth performance in healthy animals (Leeson et al., 2005; Biagi et al., 2007; Guilloteau et al., 2010; Zhang et al., 2011; Fang et al., 2014).
4. Role of butyrate in HDP expression
In addition to the positive effects of butyrate on energy supply, inflammation, barrier integrity, and gut health, recent research has indicated the ability of butyrate to modulate intestinal immunity through induction of endogenous HDP in humans and multiple livestock species.
Butyrate is capable of enhancing LL-37 transcription and translation in a time- and dose-dependent manner in a variety of human cell lines (Hase et al., 2002; Schauber et al., 2003, 2004). In addition to butyrate, other SCFA and their structural analogs such as propionate, isobutyrate, and 4-phenylbutyrate are also capable of stimulating LL-37 synthesis in human cells (Schauber et al., 2003; Steinmann et al., 2009). A direct comparison of saturated free fatty acids for their HDP-inducing activity revealed that fatty acids with 4-6 carbons are the most potent (Jiang et al., 2013). Consistently, oral administration of sodium butyrate or 4-phenylbutyrate reverses Shigella-mediated downregulation of cathelicidin in rabbits (Raqib et al., 2006; Sarker et al., 2011). Furthermore, an enema of sodium butyrate (80 mmol/L), twice daily for 3 days, increased both LL-37 mRNA levels in the rectal epithelia and LL-37 protein concentrations in the stools of human shigellosis patients (Raqib et al., 2012).
Besides LL-37, human b-defensin 1 (HBD-1) and HBD-2 are also induced by butyrate, albeit in a cell type- and gene-specific manner (Schauber et al., 2006; Schwab et al., 2008). For example, butyrate shows a minimum effect on the expression of HBD-1 and HBD-2 in primary human keratinocytes, but enhances strongly the expression of both defensins in HT-29 colonic epithelial cells, with preferential induction of HBD-2, but not HBD-1, in U937 monocytes (Schauber et al., 2006).
In chickens, 1 to 4 mmol/L sodium butyrate increases the expression of multiple, but not all, HDP in different cell types, showing a clear gene- and cell type-specific induction pattern (Sunkara et al., 2011). Among all 14 chicken b-defensins and cathelicidins, 6 b-defensins (AvBD3, AvBD4, AvBD8, AvBD9, AvBD10, and AvBD14) and 1 cathelicidin (CATH-B1) are induced to different extents, with AvBD9 showing the highest magnitude of induction. Among several chicken cell types examined, butyrate increased AvBD9 gene expression by thousands, hundreds, and tens of times in HD11 macrophage cells, primary monocytes, and intestinal explants, respectively (Sunkara et al., 2011). Despite an inability to detect the HDP protein expression levels due to a lack of specific antibodies, an increase in the bacterial killing activity of chicken monocytes has been observed following butyrate treatment, which is very likely to be mediated through HDP induction as butyrate at the concentrations used has neither a direct antimicrobial activity nor the capacity to increase oxidative burst or phagocytosis of monocytes (Sunkara et al., 2011). Consistently, dietary supplementation of 1 or 2 g/kg of sodium butyrate augments AvBD9 expression throughout the intestinal tract of chickens and the clearance of Salmonella enteritidis following an experimental infection (Sunkara et al., 2011). Among short-, medium-, and long-chain fatty acids, SCFA are the most potent, with butyrate giving the highest fold induction (Sunkara et al., 2012). Several butyrate analogs such as benzyl butyrate and glyceryl tributyrate also display an ability to increase AvBD9 expression, albeit at a lesser magnitude (Sunkara et al., 2014).
In cattle, studies with mammary epithelial cells have demonstrated the ability of 0.25, 0.5, 1 mmol/L butyrate, 1 mmol/L propionate, and 1 mmol/L hexanoate to reduce Staphylococcus aureus internalization by 50% to 60% (Ochoa-Zarzosa et al., 2009; AlvaMurillo et al., 2012). Stimulation of mammary epithelial cells with sodium butyrate followed by S. aureus infection showed a significant increase in bovine b-defensin and tracheal antimicrobial peptide (TAP) expression. Increased HDP expression was seen with 0.5 mmol/L butyrate which was associated with the greatest inhibition of S. aureus internalization (Ochoa-Zarzosa et al., 2009). These observations, along with evidence that butyrate is not toxic to S. aureus, indicate that butyrate-mediated upregulation of HDP rather than butyrate itself is likely responsible for inhibition of S. aureus internalization (Ochoa-Zarzosa et al., 2009; Alva-Murillo et al., 2012). However, it is important to note that stimulation of cells with butyrate and S. aureus also produced a 10-fold induction in nitric oxide (Ochoa-Zarzosa et al., 2009), suggesting that butyrate enhances bovine mammary gland defense by triggering both oxidative and non-oxidative mechanisms. Nevertheless, there is no increase in nitric oxide production in bovine mammary epithelial cells in response to 1 mmol/L sodium propionate or hexanoate (Alva-Murillo et al., 2012).
In porcine IPEC-J2 intestinal epithelial cells and 3D4/2 or 3D4/31 lung alveolar macrophage cells, 2 to 8 mmol/L butyrate induces the expression of multiple, but not all, porcine b-defensins and cathelicidins (PG1-5) in a time- and dose-dependent manner (Sunkara et al., 2014; Xiong et al., 2016). However, PBD1 fails to be induced in any cell type. Moreover, the magnitude of induction and optimal butyrate dose vary among different genes and cell types. For example, PBD2 is the most highly induced HDP in IPEC-J2 cells with an approximately 80-fold increase in response to 8 mmol/L butyrate (Zeng et al., 2013), but shows only a marginal induction in 3D4/31 cells at all doses applied, while PBD3 displays an impressive 200-fold induction when stimulated with 8 mmol/L butyrate (Zeng et al., 2013).
As in humans and chickens, the hydrocarbon chain length of free fatty acids is also correlated with their ability to induce HDP expression in swine. All free fatty acids with a hydrocarbon chain length of 1 to 18 are capable of inducing PBD2, PBD3, and EP2C in a dose-dependent manner (Zeng et al., 2013). However, free fatty acids with a length of four carbons or less display an increased magnitude of HDP induction with an increasing carbon number, while a length-dependent decrease in HDP induction was observed for the carbon length greater than four (Zeng et al., 2013). Additionally, 2 g/kg sodium butyrate shows the ability to alleviate the clinical symptoms of E. coli O157:H7 infection in weanling pigs and enhance bacterial clearance in 3D4/2 cells, which is associated with an increased HDP expression (Xiong et al., 2016).
5. Vitamin D
5.1. Physiological functions of vitamin D
Vitamin D is taken up directly from the diet or converted naturally from cholesterol in the skin in response to ultraviolet-B sunlight exposure. Biologically active 1a,25-dihydroxyvitamin D3 (1,25D3) is formed by activation of pre-vitamin D3 consecutively in the liver and kidney through 2 hydroxylation reactions (Svensson et al., 2016; Dimitrov and White, 2017). 1,25D3 exerts its biological activities through binding to the vitamin D receptor (VDR), which forms a heterodimer with retinoid X receptors to regulate the expression of a large group of genes (Svensson et al., 2016; Dimitrov and White, 2017). Vitamin D is well-known to be critical in calcium homeostasis and bone mineralization. Accumulating evidence has suggested a number of extra-skeletal effects on innate immunity and cancer inhibition (Svensson et al., 2016; Dimitrov and White, 2017). First, vitamin D exerts anti-inflammatory effects by reducing the expression of pro-inflammatory cytokines such as IL-1b, 1L-6, IL-8, CCL2, TNF-a, and IFN-g after pathogenic challenge (Khoo et al., 2011; Di Rosa et al., 2012; Zhang et al., 2012). Vitamin D is also capable of promoting macrophage activation and phagocytosis, while steering monocyte differentiation toward macrophages rather than dendritic cells (Xu et al., 1993; Zhu et al., 2002; Griffin et al., 2003).
5.2. Vitamin D in growth performance and disease prevention
National Research Council (NRC) recommends dietary inclusion of vitamin D at 200, 150 to 220, and 250 IU/kg for broilers, growing pigs, beef cattle, respectively, where 1 IU is equivalent to 25 ng vitamin D3. The effects of vitamin D on growth and disease prevention in livestock has not been well studied. Inclusion of vitamin D at 5,000 IU/kg in piglet diets improved intestinal morphology and the serum concentration of IFN-b, while decreasing IL-2 and IL6 serum concentrations, in the context of porcine rotavirus infection (Zhao et al., 2014). As a result, growth performance (average daily gain and average daily feed intake) of rotavirus-challenged piglets was improved in response to 5,000 IU/kg of vitamin D (Zhao et al., 2014). Similarly in dairy cattle, intramammary injection of 100 mg of 25-hydroxyvitamin D3 twice daily for 5 days has been shown to increase bacterial clearance and decrease mastitis severity, milk somatic cell counts, and body temperature, while restoring feed intake and loss of milk production in a mastitis model (Lippolis et al., 2011).
6. Impact of vitamin D on HDP expression
Besides its role in calcium homeostasis and anti-inflammation, vitamin D was recently shown to have a strong ability to induce LL-37 and HBD-2 expression in multiple human cell lines and primary cell cultures (Wang et al., 2004; Gombart et al., 2005; Hansdottir et al., 2008; Karlsson et al., 2008; Lee et al., 2012; Lowry et al., 2014). Induction of LL-37 is shown to be critical in vitamin D-mediated protection against Mycobacterium tuberculosis (Liu et al., 2007). Replication of rhinovirus is suppressed in primary bronchial epithelial cells pretreated with vitamin D, which is likely due to induction of LL-37 (Schogler et al., 2016). Consistently, a positive correlation between serum concentrations of 25- hydroxyvitamin D3 and LL-37 has been observed (Jeng et al., 2009; Dixon et al., 2012). Furthermore, oral supplementation of vitamin D increases plasma concentrations of LL-37 in both healthy (Raftery et al., 2015) and mechanically ventilated, critically ill individuals (Han et al., 2017). Vitamin D supplementation also promotes the anti-mycobacterial activity of macrophages in type 2 diabetes patients (Lopez-Lopez et al., 2014). It is noted that vitamin D-mediated induction of cathelicidin is not conserved in rodents, since murine cathelicidin gene lacks a vitamin D response element in the promoter (Dimitrov and White, 2016); however, cathelicidins and defensins can still be induced by vitamin D in livestock animals as detailed below.
In poultry, 20 and 200 ng/mL (equivalent to 48 and 480 nmol/L) vitamin D3 has been shown to induce AvBD3, AvBD6, and AvBD9 in chicken embryonic intestinal epithelial cells, while AvBD1, AvBD6, and AvBD9 were induced in a dose-dependent manner in primary monocytes (Zhang et al., 2016). Consistently, CATH-1 and CATH-B1 were dose-dependently induced by dietary vitamin D in the spleen of chickens and that induction was further enhanced by low calcium and phosphorus in the diet, although CATH-3 was suppressed (Rodriguez-Lecompte et al., 2016). However, only CATH-1 was significantly induced in response to 9,800 IU/kg of vitamin D3 supplementation in the bursa of Fabricius, while no cathelicidins were enhanced by any of the treatments in peripheral blood mononuclear cells (Rodriguez-Lecompte et al., 2016). Intraperitoneal injection of chickens with 5,000 IU/kg of body weight of vitamin D failed to upregulate HDP expression in the chicken intestinal tract, but multiple HDP were synergistically induced in response to both vitamin D and LPS (Lu et al., 2015).
Cholecalciferol, a 1,25D3 precursor, induces several b-defensins such as lingual antimicrobial peptide and bovine b-defensin 1 in bovine mammary epithelial cells, and further inhibits S. aureus internalization at 50 nmol/L (Tellez-Perez et al., 2012). S. aureus also induces all HDP investigated, but cholecalciferol inhibits the induction of HDP except for bovine neutrophil b-defensins (BNBD) 10 (Tellez-Perez et al., 2012). Vitamin D up-regulates the expression of multiple BNBD including BNBD3, BNBD4, BNBD6, BNBD7, and BNBD10 in both a time- and dose-dependent manner in bovine monocytes with 1 nmol/L observed as the optimal dose (Merriman et al., 2015). However, 4 ng/mL vitamin D alone fails to induce the expression of bovine cathelicidins 4-6 in monocytes (Nelson et al., 2010). Expression of b-defensins is further increased when monocytes are stimulated with both 1 nmol/L cholecalciferol and LPS (Merriman et al., 2015). Intramammary administration of 10 mg of 1,25D3 every 12 h for 2 days results in an induction of BNBD7 in mammary somatic cells and mammary macrophage cells (Merriman et al., 2015, 2017). Along with BNBD7, repeated injection of 1,25D3 in bovine mammary glands with subclinical mastitis also leads to an induction of BNBD4 (Merriman et al., 2017).
Very little work has been done to elucidate the effect of vitamin D on HDP expression in pigs. However, porcine cathelicidin PR-39 is induced and viral replication reduced in response to 0.5 mmol/L 25- hydroxyvitamin D3 in porcine IPEC-J2 and 5,000 IU/kg in jejunal and ileal epithelial cells of piglets challenged with rotavirus (Tian et al., 2016). Additionally, stimulation of IPEC-J2 cells with 0.5 mmol/L 25-hydroxyvitamin D3 followed by rotavirus infection increases the expression of two other porcine cathelicidins (PG1-5 and PMAP23) (Tian et al., 2016). However, it should be noted that both antiviral RIG-I (Zhao et al., 2014) and autophagy signaling pathways (Tian et al., 2016) appear to be activated by vitamin D treatment as well; therefore, relative contribution of vitamin D-mediated HDP synthesis in limiting rotavirus infection remains to be investigated.
7. Signaling mechanisms in HDP induction by butyrate and vitamin D
7.1. Butyrate induces HDP expression through histone acetylation and mitogen-activated protein kinase (MAPK) signaling pathways
Histone acetylation is an important chromatin epigenetic modification mechanism that regulates gene transcription. Histone deacetylases (HDAC) function by removing acetyl groups from histone proteins causing chromatin condensation and reduced binding of transcription factors to the gene promoter and subsequent gene transcription, whereas the opposite is true with histone acetylases (HAT) (Chen et al., 2015). The balanced action between HDAC and HAT is critical in controlling the transcription of a large group of genes. HDAC inhibitors act by suppressing HDAC enzymes, thereby facilitating histone acetylation and gene transcription (Schotterl et al., 2015). In fact, transcription of as many as 7% to 10% of human genes is affected by HDAC inhibition (Glaser et al., 2003).
Butyrate is a well-known natural HDAC inhibitor (Riggs et al., 1977; Davie, 2003) and has been shown to induce HDP gene expression primarily by acting as a HDAC inhibitor (Yedery and Jerse, 2015) (Fig. 1). Butyrate-mediated HDP induction is associated with increased acetylation of histone proteins in human EBC-1 lung epithelial cells (Kida et al., 2006), HT-29 colonic carcinoma cells, HepG2 hepatocellular carcinoma cells, and 23132/87 gastric carcinoma cells (Schauber et al., 2004), as well as chicken HD11 macrophage cells (Sunkara et al., 2012) and porcine 3D4/2 macrophage cells (Xiong et al., 2016). Consistently, structurally unrelated, but functionally similar HDAC inhibitors such as trichostatin A (Kallsen et al., 2012), sulforaphane (Schwab et al., 2008), resveratrol and its precursor or analog (Park et al., 2013; Ravagnan et al., 2013; Guo et al., 2014), curcumin (Guo et al., 2013), apicidin (Kallsen et al., 2012), and MS-275/entinostat (Kallsen et al., 2012; Miraglia et al., 2016) are all capable of inducing HDP expression. However, the HDAC inhibitory activity of an HDAC inhibitor does not always directly correlate with its ability to induce HDP gene expression. For example, a potent HDAC inhibitor such as trichostatin A is less efficient in HDP induction than a weak HDAC inhibitor such as butyrate (Schauber et al., 2004). Secondly, high concentrations of a HDAC inhibitor, which normally results in stronger HDAC inhibition, often show reduced HDP induction (Schauber et al., 2004; Sunkara et al., 2011, 2012). These results imply the involvement of other regulatory mechanisms beyond epigenetic control. In accordance with this, the MAPK and VDR pathways have been implicated in the upregulation of HDP by butyrate (Fig. 1).
Mitogen-activated protein kinase signaling cascades are comprised of three major canonical pathways including the extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 kinase pathways (Whitmarsh and Davis, 1996; Karin et al., 1997; Robinson and Cobb, 1997), with the specific pathway involved in butyrate regulation varying by cell type and gene. Inhibition of the ERK1/2 pathway using specific inhibitors has been shown to consistently attenuate butyrate-mediated induction of LL-37 in human lung epithelial cells (Kida et al., 2006) and several colonic cell lines (Schauber et al., 2003, 2004; Schwab et al., 2007). However, suppression of the ERK1/2 pathway plays no role in butyrate-induced bovine HDP expression in mammary cells (Alva-Murillo et al., 2015) and surprisingly further potentiates butyrate induction of AvBD9 in chicken HD11 macrophage (Sunkara et al., 2014). Similarly, the ERK1/2 pathway is also involved in HDP induction by butyrate derivatives such as 4-phenylbutyrate (Steinmann et al., 2009). In contrast, the p38 pathway is essential in butyrate-mediated HDP induction in human lung and Caco-2 colonic epithelial cells (Kida et al., 2006; Schwab et al., 2007), bovine mammary cells (Alva-Murillo et al., 2015), and chicken HD11 cells (Sunkara et al., 2014), but has a minimal role in LL-37 induction in human SW620 colonic epithelial cells (Schauber et al., 2003). Involvement of JNK signaling in butyrate-induced HDP expression has been shown in human lung cells (Kida et al., 2006) and chicken HD11 cells (Sunkara et al., 2014), but appears to be dispensable in bovine mammary cells (Alva-Murillo et al., 2015).
The transcription factor, AP-1, is regulated by all three canonical MAPK signaling pathways (Whitmarsh and Davis, 1996; Karin et al., 1997) and putative binding sites for AP-1 have been found in the LL37 promoter (Kida et al., 2006) and the promoters of bovine HDP (Alva-Murillo et al., 2015). In both cases, butyrate treatment was found to activate AP-1, indicating its involvement in the regulation of HDP expression. In Caco-2 cells, VDR inhibition significantly decreased LL-37 induction by butyrate or 4-phenylbutyrate (Schwab et al., 2007), suggesting that VDR is involved in the induction of HDP by butyrate. As the p38 pathway is required for butyrate induction of the VDR and Caco-2 cell differentiation (Daniel et al., 2004), it is possible that butyrate may induce LL-37 through p38 phosphorylation. Butyrate is also known to achieve some of its biological effects through interacting with its major receptors such as FFA2/GPR43 and FFA3/GPR41 (Bolognini et al., 2016); however, the role of these receptors in butyrate-mediated HDP induction remains to be determined. It is also noted that PU.1 (Termen et al., 2008) and TGF-b1 receptor kinase (Schwab et al., 2007), but not peroxisome proliferators-activated receptors g (PPARg) (Schwab et al., 2007), have been implicated in butyrate-mediated up-regulation of LL-37 in human HT-29 or Caco-2 cells.
7.2. Vitamin D induces HDP expression via VDR
Vitamin D is known to elicit its effects through binding and activation of VDR, which subsequently binds to the vitamin D response element (VDRE) in the promoter of target genes to increase transcription (Svensson et al., 2016). Indeed, inhibition of the VDR or deletion of the VDRE diminishes LL-37 induction in response to vitamin D in human keratinocytes (Schauber et al., 2003, 2006), bronchial epithelial cells (Yim et al., 2007), and pulmonary epithelial cells (Dhawan et al., 2015) (Fig. 1). While a VDRE is present in the promoter of LL-37 and HBD-2, bovine b-defensins may not be directly targeted by vitamin D, as cycloheximide, a protein translation inhibitor, can block vitamin D-mediated b-defensin induction in bovine monocytes (Merriman et al., 2015). In addition to VDR, Schauber et al. (2006) found that inhibition of the ERK1/2 pathway also significantly reduced LL-37 induction by vitamin D, indicating the involvement of the ERK1/2 pathway in regulation of the VDR.
Furthermore, Dhawan et al. (2015) found that vitamin D increases the CCAAT/enhancer-binding protein a (C/EBPa) synthesis, which subsequently induces LL-37 expression in pulmonary epithelial cells. Chromatin immunoprecipitation assays in these cells found that vitamin D recruits C/EBPa and VDR to their respective binding sites in the LL-37 promoter and that C/EBPa binding is associated with recruitment of Brahma, an ATPase of the SWI/SNF chromatin remodeling complex (Dhawan et al., 2015). Moreover, inhibition of SRC3, a major transcriptional cofactor of VDR in keratinocytes, attenuated vitamin D induction of LL-37, indicating its role in the HDP response as well (Schauber et al., 2003).
7.3. Butyrate and vitamin D signaling pathways converge to synergistically induce HDP
In addition to inducing HDP individually, concomitant stimulation with butyrate and vitamin D has been shown to produce a synergistic induction of HDP gene transcription in multiple cell lines (Fig. 1). In human keratinocytes, butyrate alone has a minimum effect on LL-37 expression, but in combination with vitamin D leads to a synergistic induction (Schauber et al., 2008). The synergy is associated with increased histone acetylation and activation of SRC3 and VDR (Schauber et al., 2008). It is not surprising that 4-phenylbutyrate also synergizes with vitamin D in LL-37 induction in human bronchial epithelial cells (Steinmann et al., 2009; Kulkarni et al., 2015) and macrophages (Rekha et al., 2015), and the VDR is critically involved in the synergy (Steinmann et al., 2009; Kulkarni et al., 2015). However, additional studies are warranted to identify other mechanisms such as the involvement of the MAPK pathways in the synergy between butyrate and vitamin D.
The discovery of links between subtherapeutic antibiotic use in livestock animals and antibiotic resistance has created a shift in public opinion and governmental policy regarding the use of antibiotics in livestock production. In order to maintain animal health and productivity, effective and reliable antibiotic alternatives are needed. Modulation of endogenous HDP synthesis by dietary compounds such as butyrate and vitamin D has emerged as a potentially viable alternative to fill this need. It is noted that, although butyrate is produced endogenously through bacterial fermentation to the millimolar concentrations in the rumen, cecum or colon, which should be sufficient in HDP induction, butyrate production in the small intestine is well below the HDP-inducing concentrations. Dietary supplementation of protected or unprotected butyrate at 1 to 2 g/kg often provides benefits to animals, particularly in the context of stress or infection. Similarly, although vitamin D3 is routinely included in the animal diet to 150 to 250 IU/ kg, much higher doses (e.g., 2,000 to 5,000 IU/kg) are needed in order to elicit a HDP-inducing and health-promoting effect. It has become clear that the molecular mechanisms involved in butyrate and vitamin D-mediated HDP synthesis vary by gene, cell type and animal species, but are primarily accomplished through chromatin remodeling, histone acetylation, and activation of the MAPK signaling pathways, leading to activation of transcription factors such as VDR and AP-1. Synergistic induction of HDP synthesis by butyrate and vitamin D appears to occur through the cooperative activation of chromatin remodeling complex and HAT and suppression of HDAC, resulting in hyper-acetylated histones and much relaxed chromatin for subsequent enhancement in gene transcription. Overall, these HDP-inducing compounds, particularly their combinations, have the ability to augment animal innate immunity and protect animals from diseases demonstrates their potential for further development as novel alternatives to antibiotics.
Conflicts of interest
The authors declare that they have no competing conflicts of interest.
This work was supported in part by Oklahoma Center for the Advancement of Science and Technology grants (AR12.2-077, HR12-051, and AR15.049), Oklahoma Agricultural Experiment Station Project (H-3025), and National Science Foundation of China grant (31528018). Kelsy Robinson was supported by a USDA-NIFA National Needs Fellowship grant (2013-38420-20500).